NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Activity
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

74 hedge funds and large institutions have $61M invested in Northwest Biotherapeutics, Inc. Common stock in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 31 increasing their positions, 16 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
-6
Holders Change %
-7.5%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
31
Reduced
16
Closed
12
Calls
$354K
Puts
$669K
Net Calls
-$315K
Net Calls Change
-$405K

Top Buyers

1
SM
1
Sabby Management
Florida
$4.84M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$857K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$3M
4
State Street
4
State Street
Massachusetts
$1.24M
5
Deutsche Bank
5
Deutsche Bank
Germany
$212K

Top Sellers

1
OAM
1
Oxford Asset Management
United Kingdom
$0
2
Zurich Cantonal Bank
2
Zurich Cantonal Bank
Switzerland
$3K
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
MLICM
4
Metropolitan Life Insurance Company (MetLife)
New York
$0
5
Millennium Management
5
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
LWM
76
Lyons Wealth Management
Florida
– -$61K -19,000 Closed
Arrowstreet Capital
77
Arrowstreet Capital
Massachusetts
– -$51K -15,890 Closed
MC
78
Moors & Cabot
Massachusetts
– -$30K -10,000 Closed
BNP Paribas Financial Markets
79
BNP Paribas Financial Markets
France
– -$30.2K -9,432 Closed
PAM
80
Panagora Asset Management
Massachusetts
– -$19K -6,036 Closed
JPMorgan Chase & Co
81
JPMorgan Chase & Co
New York
– -$5K -1,683 Closed
1 2 3
4